» Articles » PMID: 7932100

[Studies on the Pharmacodynamics of Ginsenoside-Rg1, -Rb1 and -Rb2 in Rats]

Overview
Journal Yakugaku Zasshi
Specialties Pharmacology
Pharmacy
Date 1994 Aug 1
PMID 7932100
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The pharmacodynamics of ginsenoside-Rg1 (Rg1), -Rb1 (Rb1) and -Rb2 (Rb2) in rats were studied. In these studies, obvious differences were found in their pharmacodynamics. That is, Rg1 was easily hydrated to the same prospogenins in both rat stomach and 0.1 N HCl solution, but Rb1 and Rb2 were little decomposed (metabolised) in rat stomach and a small quantity of their hydroperoxide derivatives were found, but they were easily hydrated to their prosapogenins by 0.1 N HCl. These ginsenosides were decomposed (metabolised) to several prosapogenins by enteric bacteria and enteric enzymes. The modes of their decomposition (metabolism) were respectively different. In particular, the terminal sugar moiety at the C-20 hydroxy group was noted to affect the rates of their decomposition. The amount of Rg1 and Rb1 absorbed from the gastrointestinal tract of rat were 1.9% and 0.1% of the dose, respectively. And that of Rb2 was determined to be 3.7% of the dose by using 3H-labeled Rb2. Rg1 was excreted into the urine and bile in a 2:5 ratio. Rb1 and Rb2 were mainly excreted into the urine.

Citing Articles

Metabolism and drug interactions of Korean ginseng based on the pharmacokinetic properties of ginsenosides: Current status and future perspectives.

Park J J Ginseng Res. 2024; 48(3):253-265.

PMID: 38707645 PMC: 11068998. DOI: 10.1016/j.jgr.2024.02.003.


A narrative review of the pharmacology of ginsenoside compound K.

Liu T, Zhu L, Wang L Ann Transl Med. 2022; 10(4):234.

PMID: 35280413 PMC: 8908159. DOI: 10.21037/atm-22-501.


Fermented Korean Red Ginseng Extract Enriched in Rd and Rg3 Protects against Non-Alcoholic Fatty Liver Disease through Regulation of mTORC1.

Choi S, Park J, Shon C, Lee C, Ryu J, Son D Nutrients. 2019; 11(12).

PMID: 31817227 PMC: 6949916. DOI: 10.3390/nu11122963.


Non-clinical pharmacokinetic behavior of ginsenosides.

Won H, Kim H, Park T, Kim H, Jo K, Jeon H J Ginseng Res. 2019; 43(3):354-360.

PMID: 31308806 PMC: 6606970. DOI: 10.1016/j.jgr.2018.06.001.


Active ginseng components in cognitive impairment: Therapeutic potential and prospects for delivery and clinical study.

Jakaria M, Haque M, Kim J, Cho D, Kim I, Choi D Oncotarget. 2018; 9(71):33601-33620.

PMID: 30323902 PMC: 6173364. DOI: 10.18632/oncotarget.26035.